Inscrição na biblioteca: Guest
Portal Digital Begell Biblioteca digital da Begell eBooks Diários Referências e Anais Coleções de pesquisa
Critical Reviews™ in Oncogenesis
SJR: 0.631 SNIP: 0.503 CiteScore™: 2

ISSN Imprimir: 0893-9675
ISSN On-line: 2162-6448

Critical Reviews™ in Oncogenesis

Editor-in-Chief: Benjamin Bonavida

Conselho editorial

Fahd Al-Mulla
Faculty of Medicine, Department of Pathology, Kuwait University Health Sciences Centre, Safat, Kuwait

Philip M. Arlen
Neogenix Oncology, Inc. Rockville; and Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892-1750, USA

M. Zouhair Atassi
Baylor College of Medicine

Menashe Bar-Eli
Department of Cancer Biology, The University of Texas M. D. Anderson Cancer Center, Houston, TX

James R. Berenson
Institute for Myeloma and Bone Cancer Research, West Hollywood, CA, USA

Eli Canaani
Weizmann Institute of Science, Rehovot, Israel

Roger J. Daly
St Vincent's Hospital Clinical School, Department of Medicine, University of New South Wales ; Cancer Research Program, Garvan Institute of Medical Research Sydney, New South Wales, Australia

James Economou
David Geffen School of Medicine, Jonsson Comprehensive Cancer Center, University of California at Los Angeles, California, USA

Thomas Efferth
Department of Pharmaceutical Biology Institute of Pharmacy and Biochemistry Johannes Gutenberg University, Mainz, Germany

Wafik El Deiry
University of Pennsylvania, Philadelphia, USA

Jean-Francois Jeannin
EPHE Tumor Immunology and Immunotherapy, Laboratory, University of Burgundy, Dijon, France

No-Hee Park
The Shapiro Family Laboratory of Viral Oncology and Aging Research; Division of Constitutive and Regenerative Sciences, UCLA School of Dentistry; David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA

Antonio Russo
Università degli Studi di Palermo Palermo, Italy

Eric Solary
Institut de Cancérologie Gustave Roussy, Villejuif, France

Demetrios A. Spandidos
Department of Applied Biochemistry and Immunology, Institute of Molecular Biology and Biotechnology, Laboratory of Clinical Virology, Faculty of Medicine, University of Crete, Heraklion, Crete, Greece

Eitan Yefenof
Hebrew University of Jerusalem, Jerusalem, Israel

Nadia Zaffaroni
Fondazione IRCCS Istituto Nazionale Tumori

Jiren Zhang
Cancer Center, Zhujiang Hospital, Southern Medical University, Guangzhou, China

Critical Reviews™ in Oncogenesis

Extrinsic and intrinsic apoptotic pathways.Vol. 13, Iss. 1, Molecular Mechanisms of Apoptosis in Prostate Cancer. Extrinsic and intrinsic apoptotic pathways.Vol. 13, Iss. 1, Molecular Mechanisms of Apoptosis in Prostate Cancer. Molecular Mechanisms of Apoptosis in Prostate Cancer
RTK signaling via RAS/MAPK and PI(3)K pathways. Vol. 13, Iss.1, Aberrant Receptor Signaling and Trafficking as Mechanisms in Oncogenesis. RTK signaling via RAS/MAPK and PI(3)K pathways. Vol. 13, Iss.1, Aberrant Receptor Signaling and Trafficking as Mechanisms in Oncogenesis. Aberrant Receptor Signaling and Trafficking as Mechanisms in Oncogenesis
Adaptive Treg cells are induced in the tumor microenvironment. Vol. 14, Iss. 1, Role for the cAMP-Protein Kinase A Signaling Pathway in Suppression of Antitumor Immune Responses by Regulator... Adaptive Treg cells are induced in the tumor microenvironment. Vol. 14, Iss. 1, Role for the cAMP-Protein Kinase A Signaling Pathway in Suppression of Antitumor Immune Responses by Regulator... Role for the cAMP-Protein Kinase A Signaling Pathway in Suppression of Antitumor Immune Responses by Regulatory T Cells
The MLL protein complex.Vol. 15, Iss. 1-2, Structural and Expression Changes of Septins in Myeloid Neoplasia. The MLL protein complex.Vol. 15, Iss. 1-2, Structural and Expression Changes of Septins in Myeloid Neoplasia. Structural and Expression Changes of Septins in Myeloid Neoplasia